Hydroxia Esseti Farmaceutici

Glutathione Sodium, the active ingredient in Hydroxia Esseti Farmaceutici, is an antioxidant presented as an injectable solution for intramuscular and intravenous use. It helps replenish cellular glutathione levels and supports redox balance in patients with oxidative stress or glutathione deficiency.

GNH USA supplies Hydroxia Esseti Farmaceutici as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies, clinics and clinical research facilities worldwide.

Hydroxia Esseti Farmaceutici, containing glutathione sodium, is used in clinical settings that require antioxidant support or correction of glutathione deficiency. - Glutathione deficiency: restores intracellular glutathione concentrations and improves cellular antioxidant capacity. - Oxidative stress conditions: provides systemic antioxidant support to mitigate tissue damage. - Liver disorders: adjunct therapy to support hepatic detoxification and protect against oxidative injury.

Glutathione sodium injection may be associated with a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Injection site pain or erythema: mild discomfort at the site of administration. - Nausea or vomiting: transient gastrointestinal upset. - Headache: mild to moderate intensity. - Dizziness or flushing: transient circulatory sensations.

Serious or Rare Side Effects: - Anaphylactic reaction: severe hypersensitivity requiring immediate medical intervention. - Hemolysis in G6PD‑deficient patients: rapid destruction of red blood cells. - Acute renal failure: unexpected decline in kidney function, especially with high‑dose or prolonged therapy.

Before initiating therapy, clinicians should consider several safety measures. - Assess hypersensitivity: review patient allergy history prior to administration. - Monitor liver function: check hepatic enzymes during treatment. - Avoid in G6PD deficiency: risk of hemolysis warrants contraindication. - Use cautiously in renal impairment: adjust infusion rate and monitor renal parameters. - Observe during infusion: watch for signs of anaphylaxis or hypotension. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze.

Glutathione sodium can interact with other agents, requiring attention to potential additive or antagonistic effects.

Major Interactions (Avoid): - High‑dose vitamin C: may compete for redox pathways and reduce glutathione efficacy. - Concurrent antioxidant therapy: excessive antioxidant load can blunt intended therapeutic effects.

Moderate Interactions (Monitor Closely): - Warfarin: monitor INR as glutathione may influence vitamin K metabolism. - Diuretics: watch electrolyte balance, especially potassium. - ACE inhibitors: observe blood pressure for additive hypotensive effects.